Impax Reduces Holdings in Chemed

Summary

Impax Asset Management Group PLC decreased its stake in Chemed Corporation (NYSE: CHE) by 9.3% during the first quarter, currently holding 301,580 shares valued at approximately $185.57 million. Other institutional investors, including Neuberger Berman and FMR LLC, also adjusted their holdings. Chemed reported quarterly EPS of $5.63, exceeding expectations, and declared a dividend of $0.50 per share. The stock opened at $472.61 with a market capitalization of $6.91 billion and a P/E ratio of 23.02. Analysts maintain positive ratings, with RBC’s target price set at $640.00.Market Beat

Impact Analysis

First-order effects of Impax reducing its stake in Chemed may include a negative signal to the market, potentially affecting investor sentiment and stock price volatility. The decrease in holdings by multiple institutional investors could be interpreted as caution towards Chemed’s future performance, despite its recent earnings beat.Market Beat+ 3 Second-order effects might involve changes in the competitive landscape as other investment firms adjust their positions. Copeland Capital Management and Boston Trust Walden Company’s contrasting actions suggest differing views on Chemed’s market potential.Market Beat+ 2 Investment opportunities could emerge from the stock’s adjusted valuations as analysts, such as RBC, maintain a positive outlook with a target price of $640, indicating potential upside.Market Beat